Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study

To report the safety and efficacy of anti-tumor necrosis factor α (TNFα) therapy in severe and refractory neuro-Behçet disease (NBD) patients. Observational, multicenter study including 17 BD patients (70.6% of male, with a median age of 39.3 [24–60] years), with symptomatic parenchymal NBD, refract...

Descripción completa

Detalles Bibliográficos
Autores principales: Desbois, Anne Claire, Addimanda, Olga, Bertrand, Anne, Deroux, Alban, Pérard, Laurent, Depaz, Raphael, Hachulla, Eric, Lambert, Marc, Launay, David, Subran, Benjamin, Ackerman, Felix, Mariette, Xavier, Cohen, Fleur, Marie, Isabelle, Salvarini, Carlo, Cacoub, Patrice, Saadoun, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907644/
https://www.ncbi.nlm.nih.gov/pubmed/27281066
http://dx.doi.org/10.1097/MD.0000000000003550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907644/
https://www.ncbi.nlm.nih.gov/pubmed/27281066
http://dx.doi.org/10.1097/MD.0000000000003550

Ejemplares similares